US Markets

Switzerland nears deal to get Moderna COVID vaccine, official says

Credit: REUTERS/Brian Snyder

Switzerland is close to signing a deal to secure access for a coronavirus vaccine being developed by Moderna of the U.S., a government official has said.

ZURICH, Aug 5 (Reuters) - Switzerland is close to signing a deal to secure access for a coronavirus vaccine being developed by Moderna MRNA.O of the U.S., a government official has said.

Switzerland will soon sign a reservation and supply deal, Pascal Strupler, the director of the Federal Office of Public Health, told the Swiss TV programme Club late on Tuesday.

"We are only a few hours away from completing a purchase contract. With this contract we will get it very quickly," Strupler said.

He declined to give financial details of any deal.

If the vaccine passes trials and is authorised for use, it could be produced in Switzerland under a deal between drugmaker Lonza LONN.S and Moderna.

(Reporting by John Revill; Editing by Kevin Liffey)

((John.Revill@thomsonreuters.com; +41 58306 7022; Reuters Messaging: john.revill.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More